| Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation (NCT00447902) | Boehringer Ingelheim | 2007-03-01 |
| Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers (NCT02214992) | Boehringer Ingelheim | 2007-03-01 |
| Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers (NCT02214979) | Boehringer Ingelheim | 2007-03-01 |
| Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers (NCT02258971) | Boehringer Ingelheim | 2007-03-01 |
| A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler (NCT02172560) | Boehringer Ingelheim | 2007-03-01 |
| Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life (NCT00619177) | Boehringer Ingelheim | 2007-03-01 |
| Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. (NCT00452400) | Boehringer Ingelheim | 2007-03-01 |
| Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease (NCT00539214) | Boehringer Ingelheim | 2007-03-01 |
| BI 2536 Second Line Monotherapy in SCLC (NCT00412880) | Boehringer Ingelheim | 2007-02-14 |
| Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression (NCT02229825) | Boehringer Ingelheim | 2007-02-09 |
| Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers (NCT02183363) | Boehringer Ingelheim | 2007-02-01 |
| Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life (NCT00539461) | Boehringer Ingelheim | 2007-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes (NCT02211963) | Boehringer Ingelheim | 2007-02-01 |
| BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus (NCT02183324) | Boehringer Ingelheim | 2007-02-01 |
| SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC (NCT00440271) | Boehringer Ingelheim | 2007-02-01 |
| Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers (NCT02183337) | Boehringer Ingelheim | 2007-02-01 |
| Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers (NCT02226978) | Boehringer Ingelheim | 2007-02-01 |
| Effect of BIBW 2948 BS in COPD (NCT00423137) | Boehringer Ingelheim | 2007-01-17 |
| Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects (NCT02182388) | Boehringer Ingelheim | 2007-01-01 |
| Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers (NCT02211937) | Boehringer Ingelheim | 2007-01-01 |
| Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers (NCT02263989) | Boehringer Ingelheim | 2007-01-01 |
| BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer (NCT00708214) | Boehringer Ingelheim | 2007-01-01 |
| Survey on PD Patients With Depressive Symptoms (NCT00614575) | Boehringer Ingelheim | 2007-01-01 |
| Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives (NCT00539487) | Boehringer Ingelheim | 2007-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 10773 in Healthy Male Subjects (NCT02172170) | Boehringer Ingelheim | 2007-01-01 |
| Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors (NCT00730821) | Boehringer Ingelheim | 2007-01-01 |
| Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers (NCT02254135) | Boehringer Ingelheim | 2006-12-01 |
| Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects (NCT02194179) | Boehringer Ingelheim | 2006-12-01 |
| Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters (NCT00615108) | Boehringer Ingelheim | 2006-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers (NCT02214914) | Boehringer Ingelheim | 2006-11-01 |
| A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients (NCT00402233) | Boehringer Ingelheim | 2006-11-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes (NCT02212925) | Boehringer Ingelheim | 2006-11-01 |
| An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer (NCT00425854) | Boehringer Ingelheim | 2006-11-01 |
| Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) (NCT00400153) | Boehringer Ingelheim | 2006-11-01 |
| Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients. (NCT00388882) | Boehringer Ingelheim | 2006-10-04 |
| Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults (NCT00389207) | Boehringer Ingelheim | 2006-10-01 |
| A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. (NCT00390689) | Boehringer Ingelheim | 2006-10-01 |
| Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers (NCT02253940) | Boehringer Ingelheim | 2006-10-01 |
| Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer (NCT02211833) | Boehringer Ingelheim | 2006-10-01 |
| Safety, Tolerability and Pharmacokinetics Study of BI 1744 CL in Healthy Male Subjects (NCT02172131) | Boehringer Ingelheim | 2006-10-01 |
| BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia (NCT00701766) | Boehringer Ingelheim | 2006-10-01 |
| Phase II Study of BI 2536 in Prostate Cancer (NCT00706498) | Boehringer Ingelheim | 2006-09-01 |
| Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers (NCT02182193) | Boehringer Ingelheim | 2006-09-01 |
| TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium (NCT00886288) | Boehringer Ingelheim | 2006-09-01 |
| Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers (NCT02212938) | Boehringer Ingelheim | 2006-09-01 |
| Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers (NCT02264132) | Boehringer Ingelheim | 2006-09-01 |
| Tiotropium / Respimat One Year Study in COPD. (NCT00387088) | Boehringer Ingelheim | 2006-09-01 |
| Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study) (NCT00617019) | Boehringer Ingelheim | 2006-09-01 |
| Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers (NCT02194309) | Boehringer Ingelheim | 2006-09-01 |
| Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers (NCT02254720) | Boehringer Ingelheim | 2006-09-01 |
| Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects (NCT02182323) | Boehringer Ingelheim | 2006-09-01 |
| A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS (NCT00375284) | Boehringer Ingelheim | 2006-09-01 |
| Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy (NCT00431067) | Boehringer Ingelheim | 2006-09-01 |
| Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients (NCT02172534) | Boehringer Ingelheim | 2006-09-01 |
| Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV (NCT02229760) | Boehringer Ingelheim | 2006-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Powder in Healthy Male Subjects (NCT02209844) | Boehringer Ingelheim | 2006-08-01 |
| Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer (NCT00710710) | Boehringer Ingelheim | 2006-08-01 |
| An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma (NCT00365560) | Boehringer Ingelheim | 2006-08-01 |
| Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients. (NCT00531206) | Boehringer Ingelheim | 2006-08-01 |
| Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer (NCT00376623) | Boehringer Ingelheim | 2006-07-25 |
| A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer (NCT00801294) | Boehringer Ingelheim | 2006-07-01 |
| A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. (NCT00359788) | Boehringer Ingelheim | 2006-07-01 |
| Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg (NCT00350207) | Boehringer Ingelheim | 2006-07-01 |
| Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances (NCT00356096) | Boehringer Ingelheim | 2006-07-01 |
| Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients (NCT02215798) | Boehringer Ingelheim | 2006-07-01 |
| A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS (NCT00349531) | Boehringer Ingelheim | 2006-07-01 |
| Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers (NCT02183610) | Boehringer Ingelheim | 2006-07-01 |
| Metabolism and Pharmacokinetics of [14C]- BIBW 2992 MA2 in Healthy Male Volunteers (NCT02171689) | Boehringer Ingelheim | 2006-07-01 |
| An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke (NCT02229890) | Boehringer Ingelheim | 2006-06-01 |
| Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients. (NCT00347295) | Boehringer Ingelheim | 2006-06-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers (NCT02183311) | Boehringer Ingelheim | 2006-06-01 |
| A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours (NCT02182128) | Boehringer Ingelheim | 2006-06-01 |
| Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers (NCT02171039) | Boehringer Ingelheim | 2006-06-01 |
| Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis (NCT00333411) | Boehringer Ingelheim | 2006-06-01 |
| Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers (NCT02171052) | Boehringer Ingelheim | 2006-06-01 |
| Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers (NCT02171507) | Boehringer Ingelheim | 2006-05-01 |
| Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension (NCT00326768) | Boehringer Ingelheim | 2006-05-01 |
| Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers (NCT02259816) | Boehringer Ingelheim | 2006-05-01 |
| Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) (NCT00321854) | Boehringer Ingelheim | 2006-05-01 |
| Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) (NCT02231918) | Boehringer Ingelheim | 2006-05-01 |
| Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities (NCT00621582) | Boehringer Ingelheim | 2006-05-01 |
| Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients (NCT00328172) | Boehringer Ingelheim | 2006-05-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers (NCT02183298) | Boehringer Ingelheim | 2006-05-01 |
| Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects (NCT02171468) | Boehringer Ingelheim | 2006-05-01 |
| Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers (NCT02253927) | Boehringer Ingelheim | 2006-05-01 |
| Secondary Prevention of Venous Thrombo Embolism (VTE). (NCT00329238) | Boehringer Ingelheim | 2006-05-01 |
| General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment (NCT00319813) | Boehringer Ingelheim | 2006-04-19 |
| Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort (NCT02242292) | Boehringer Ingelheim | 2006-04-01 |
| Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers (NCT02171013) | Boehringer Ingelheim | 2006-04-01 |
| Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers (NCT02259946) | Boehringer Ingelheim | 2006-04-01 |
| Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult Volunteers (NCT02226991) | Boehringer Ingelheim | 2006-04-01 |
| Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes (NCT00309608) | Boehringer Ingelheim | 2006-04-01 |
| Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension (NCT02242344) | Boehringer Ingelheim | 2006-04-01 |
| Profile of Depressive Symptoms in Parkinsons Disease (NCT00349310) | Boehringer Ingelheim | 2006-04-01 |
| Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS) (NCT02248155) | Boehringer Ingelheim | 2006-04-01 |
| JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme (NCT00311402) | Boehringer Ingelheim | 2006-04-01 |
| Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers (NCT02261103) | Boehringer Ingelheim | 2006-04-01 |
| PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder (NCT00340704) | Boehringer Ingelheim | 2006-04-01 |
| Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient) (NCT02243566) | Boehringer Ingelheim | 2006-04-01 |
| Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension (NCT00281580) | Boehringer Ingelheim | 2006-04-01 |